The LAMEA defibrillators market has a potential to reach $ 2,847.8 million by 2022. The defibrillation procedure is used to deliver an electric shock to the heart, depolarizing the heart muscles and restoring the heart to its normal electric impulse. Growing interest in public access defibrillator (PAD) by the public & private organizations has led the market to witness unprecedented growth.
The report highlights the adoption of Defibrillators in LAMEA region. Based on the product type; the Defibrillators market is segmented into Advanced Life Support (ALS) Defibrillators, Automated External Defibrillators (AEDs), Implantable Cardioverter Defibrillators (ICD), Wearable Defibrillators market. Further the Implantable Cardioverter Defibrillators (ICD) segment is sub segmented into Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs) market. Based on the end use avenue, the market is bifurcated into Hospitals, Pre-hospitals, Public Access Markets, Alternate Care Markets, Home Healthcare market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA.
The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
Key Topics Covered:
1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
1.5 Methodology For The Research
2. LAMEA Defibrillators Market Overview
2.1 LAMEA Defibrillators Market, By Country
3. LAMEA Defibrillators Market, By Product Type
4. LAMEA Defibrillators Market, By End Use
5. Country Wise Defibrillators Market
6. Company Profiles
- Asahi Kasei Corporation
- Stryker Corporation
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Medtronic plc
- LivaNova PLC
- St. Jude Medical, Inc
- Cardiac Science Corporation
- Nihon Koden Corporation
- Koninklijke Philips N.V.
For more information about this report visit http://www.researchandmarkets.com/research/lx466z/lamea